These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 20457501)

  • 1. The effect of milk components, especially of casein, on the bioavailability of ciprofloxacin tablets cannot be evaluated by dissolution testing.
    Simon Z
    J Pharm Biomed Anal; 2010 Nov; 53(3):819; author reply 819-20. PubMed ID: 20457501
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro food-drug interaction study: Which milk component has a decreasing effect on the bioavailability of ciprofloxacin?
    Pápai K; Budai M; Ludányi K; Antal I; Klebovich I
    J Pharm Biomed Anal; 2010 May; 52(1):37-42. PubMed ID: 20053516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioavailability of ciprofloxacin tablets in humans and its correlation with the dissolution rates.
    Khan MK; Khan MF; Khan H; Mustafa G
    Pak J Pharm Sci; 2009 Jul; 22(3):329-34. PubMed ID: 19553184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Five Alive fruit juice on the dissolution and absorption profiles of ciprofloxacin.
    Akinleye MO; Coker HA; Chukwuani CM; Adeoye AW
    Nig Q J Hosp Med; 2007; 17(1):53-7. PubMed ID: 17688173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statistical evaluation of in vitro dissolution of different brands of ciprofloxacin hydrochloride tablets and capsules.
    Tang Y; Gan K
    Drug Dev Ind Pharm; 1998 Jun; 24(6):549-52. PubMed ID: 9876621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of chloroquine on the bioavailability of ciprofloxacin in man.
    Ilo EC; Orisakwe OE; Ilondu NA; Okwoli N; Brown SA; Elo-Ilo J; Agbasi PU
    J Control Release; 2006 Nov; 116(2):e109-10. PubMed ID: 17718943
    [No Abstract]   [Full Text] [Related]  

  • 7. Prediction of in vivo bioavailability of six brands of ciprofloxacin film coated tablets using the concept dissolution efficiency (DE).
    Ofoefule SI; Udeogaranya PO; Okonta JM
    Boll Chim Farm; 2001; 140(3):187-91. PubMed ID: 11486612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An empirical assessment of the possibility of interchangeability between multisource ciprofloxacin hydrochloride tablets marketed in Nigeria.
    Osadebe PO; Esimone OC; Akabogu IC
    Boll Chim Farm; 2003 Oct; 142(8):352-6. PubMed ID: 15040466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disposition kinetics of ciprofloxacin in lactating goats.
    el-Banna HA; Abo el-Sooud K
    Dtsch Tierarztl Wochenschr; 1998 Jan; 105(1):35-8. PubMed ID: 9499632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative bioavailability of two oral formulations of ciprofloxacin.
    Trejo D; Toledo A; Carrasco-Portugal Mdel C; Aguilar-Cota ME; Herrera JE; Flores-Murrieta FJ
    Proc West Pharmacol Soc; 2003; 46():134-5. PubMed ID: 14699910
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of milk consumption on the pharmacokinetics of fleroxacin and ciprofloxacin in healthy volunteers.
    Hoogkamer JF; Kleinbloesem CH
    Drugs; 1995; 49 Suppl 2():346-8. PubMed ID: 8549357
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro evaluation of the dissolution behaviour of itraconazole in bio-relevant media.
    Ghazal HS; Dyas AM; Ford JL; Hutcheon GA
    Int J Pharm; 2009 Jan; 366(1-2):117-23. PubMed ID: 18832020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of two balanced salt solutions on the bioavailability of ofloxacin and ciprofloxacin.
    Osato MS
    Adv Ther; 1999; 16(5):200-9. PubMed ID: 10915395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of food effects on the absorption of celecoxib based on biorelevant dissolution testing coupled with physiologically based pharmacokinetic modeling.
    Shono Y; Jantratid E; Janssen N; Kesisoglou F; Mao Y; Vertzoni M; Reppas C; Dressman JB
    Eur J Pharm Biopharm; 2009 Sep; 73(1):107-14. PubMed ID: 19465123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioequivalence evaluation of 2 different oral formulations of ciprofloxacin in healthy volunteers.
    Galicia I; Frias-Iniesta J; Carcas AJ; Soto A; Gomez E; Miranda E; Fernandez A; Montuenga C
    Int J Clin Pharmacol Ther; 1998 May; 36(5):282-5. PubMed ID: 9629993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aqueous and vitreous penetration of topically applied ciprofloxacin and ofloxacin.
    Taustine LR
    J Cataract Refract Surg; 2004 Jan; 30(1):6. PubMed ID: 14967251
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative bioavailability of two brands of ciprofloxacin.
    Seth SD; Beotra A; Seth S
    J Assoc Physicians India; 1995 May; 43(5):327-30. PubMed ID: 9081961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Casein hydrolysate as a rapid and/or enteric dissolving additive for oral drugs.
    Imai T; Nishiyama T; Shameem M; Otagiri M
    Pharm Dev Technol; 1998 May; 3(2):225-32. PubMed ID: 9653760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of bovine in vivo bioavailability of two sulfamethazine oral boluses exhibiting different in vitro dissolution profiles.
    Martinez MN; Kawalek JC; Howard KD; Ward JL; Marroum P; Marnane W; Bensley D; Pelsor FR; Hoag S; Tatavarti AS; Xie L; Fahmy R
    J Vet Pharmacol Ther; 2006 Dec; 29(6):459-67. PubMed ID: 17083449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solubility behavior and biopharmaceutical classification of novel high-solubility ciprofloxacin and norfloxacin pharmaceutical derivatives.
    Breda SA; Jimenez-Kairuz AF; Manzo RH; Olivera ME
    Int J Pharm; 2009 Apr; 371(1-2):106-13. PubMed ID: 19150493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.